In effect, miR-342-5p downregulated Bcl-xL protein expression from 2.5 to 5-fold in osteosarcoma cell lines and significantly decreased the activity of the WT-BCL2L1-3′UTR vector by 4.2-fold in HOS cells. The gene discussed is BCL2L1; the disease is osteosarcoma.